Corrigendum to: Depressive symptoms, cognitive impairment, and metabolic syndrome in community-dwelling elderly in Southern Taiwan (Psychogeriatrics, (2015), 15, 2, (109-115), 10.1111/psyg.12080);Depressive symptoms, cognitive impairment, and metabolic syndrome in community-dwelling elderly in Southern Taiwan

Psychogeriatrics

Volumn 15, Issue 2, 2015, Pages 109-115

  Chang, Ting Ting ^a   Lung, For Wey ^b,c,d   Yen, Yung Chieh ^a,e  

^a E DA HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

Author keywords

Cognitive impairment; Depression; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ARTICLE; COGNITIVE DEFECT; COMMUNITY LIVING; DEPRESSION; DEPRESSION ASSESSMENT; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE; SOCIOECONOMICS; STRUCTURAL EQUATION MODELING; TAIWAN; TAIWANESE DEPRESSION QUESTIONNAIRE;

EID: 84930752249     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/psyg.12228     Document Type: Erratum

References (51)

1. Madden J. Non-dementing psychoses in older persons. JAMA 1952; 150: 1567-1570.
2. McNeil JK. Neuropsychological characteristics of the dementia syndrome of depression: onset, resolution, and three-year follow-up. Clin Neuropsychol 1999; 13: 136-146.
3. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression-possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-206.
4. Mitchell AJ, Dening TR. Depression-related cognitive impairment: possibilities for its pharmacological treatment. J Affect Disord 1996; 36: 79-87.
5. Jost BC, Grossberg GT. The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. J Am Geriatr Soc 1996; 44: 1078-1081.
6. Lyketsos CG, Lopez O, Jones B etal. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment-results from the cardiovascular health study. JAMA 2002; 288: 1475-1483.
7. Garre-Olomo J, Lopez-Sousa S, Vitalta-Franch J etal. Evolution of depressive symptoms in Alzheimer disease: one-year follow-up. Alzheimer Dis Assoc Disord 2003; 17: 77-85.
8. Vanhanen M, Koivisto K, Moilanen L etal. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006; 67: 843-847.
9. Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and Alzheimer disease. Arch Neurol 2007; 64: 93-96.
10. Ho RC, Niti M, Yap KB etal. Metabolic syndrome and cognitive decline in Chinese adults: results from the Singapore Longitudinal Ageing Studies. Am J Geriatr Psychiatry 2008; 16: 519-522.
11. Meyers BS, Bruce ML. The depression-dementia conundrum: integrating clinical and epidemiological perspectives. Arch Gen Psychiatry 1998; 55: 1082-1083.
12. Jorm AF. Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000; 46: 219-227.
13. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry 2001; 35: 776-781.
14. Schweitzer I, Tuckwell V, O'Brien J etal. Is late onset depression a prodrome to dementia? Int J Geriatr Psychiatry 2002; 17: 997-1005.
15. Devanand DP, Sano M, Tang MX etal. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996; 53: 175-182.
16. Berger A-K, Fratiglioni L, Forsell Y etal. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999; 53: 1998-2002.
17. Wilson RS, Barnes LL, Mendes de Leon CF etal. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002; 59: 364-370.
18. Barnes DE, Alexopoulos GS, Lopez OL etal. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006; 63: 273-279.
19. Yaffe K, Blackwell T, Gore R etal. Depressive symptoms and cognitive decline in non-demented elderly women: a prospective study. Arch Gen Psychiatry 1999; 56: 425-430.
20. Paterniti S, Verdier-Taillefer MH, Dufouil C etal. Depressive symptoms and cognitive decline in elderly people. Longitudinal study. Br J Psychiatry 2002; 181: 406-410.
21. Wilson RS, Mendes De Leon CF, Bennett DA etal. Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry 2004; 75: 126-129.
22. Lavretsky H, Ercoli L, Siddarth P etal. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia. Am J Geriatr Psychiatry 2003; 11: 667-673.
23. Ganguli M, Du Y, Dodge HH etal. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry 2006; 63: 153-160.
24. Yaffe K, Kanaya A, Lindquist K etal. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
25. Dik MG, Jonker C, Comijs HC etal. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007; 30: 2655-2660.
26. Komulainen P, Lakka TA, Kivipelto M etal. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 2007; 23: 29-34.
27. Laudisio A, Marzetti E, Pagano F etal. Association of metabolic syndrome with cognitive function: the role of sex and age. Clin Nutr 2008; 27: 747-754.
28. Muller M, Tang MX, Schupf N etal. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 2007; 24: 185-192.
29. van den Berg E, Biessels GJ, de Craen AJ etal. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 2007; 69: 979-985.
30. Yaffe K, Haan M, Blackwell T etal. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 2007; 55: 758-762.
31. Campayo A, de Jonge P, Roy JF etal. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry 2010; 167: 580-588.
32. Weissman MM, Sholomskas D, Pottenger M etal. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106: 203-214.
33. Lee Y, Yang MJ, Lai TJ etal. Development of the Taiwanese depression questionnaire. Chang Gung Med J 2000; 23: 688-694.
34. Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 1981; 36: 428-434.
35. Pfeiffer E. A Short Portable Mental Status Questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975; 23: 433-441.
36. Chi I, Boey KW. Validation of Measuring Instruments of Mental Health Status of the Elderly in Hong Kong. Hong Kong: Department of Social Work and Administration, University of Hong Kong, 1992.
37. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
38. Yen YC, Liu CK, Lung FW etal. Apolipoprotein E polymorphism and Alzheimer's disease. Kaohsiung J Med Sci 2001; 17: 190-197.
39. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
40. Wenhama PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-1159.
41. Yen YC, Rebok GW, Yang MJ etal. A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 479-486.
42. Lupien SJ, de Leon M, de Santi S etal. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998; 1: 69-73.
43. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
44. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
45. Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000; 23: 542-549.
46. Biessels GJ, Staekenborg S, Brunner E etal. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006; 5: 64-74.
47. Banks WA. The source of cerebral insulin. Eur J Pharmacol 2004; 490: 5-12.
48. Steen E, Terry BM, Rivera EJ etal. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 2005; 7: 63-80.
49. Bondy CA, Cheng CM. Signaling by insulin-like growth factor 1 in brain. Eur J Pharmacol 2004; 490: 25-31.
50. Yaffe K. Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis Assoc Disord 2007; 21: 167-171.
51. Viscogliosi G, Andreozzi P, Chiriac IM etal. Depressive symptoms in older people with metabolic syndrome: is there a relationship with inflammation? Int J Geriatr Psychiatry 2013; 28: 242-247.